Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder.

× No keyword cloud information.

25 in total

Review 1. The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials.

Authors: Richard J Sylvester; Willem Oosterlinck; J Alfred Witjes
Journal: Eur Urol Date: 2008-01-15 Impact factor: 20.096

Review 2. Invasive bladder cancer--possible future treatment considerations.

Authors: R A Gardiner
Journal: Urol Res Date: 1986

3. Prophylactic treatment for superficial bladder cancer following transurethral resection.

Authors: Y Hirao; E Okajima; S Ohara; S Ozono; T Hiramatsu; K Yoshida; K Yamada; H Aoyama; M Hashimoto; S Watanabe
Journal: Cancer Chemother Pharmacol Date: 1987 Impact factor: 3.333

Review 4. Chemotherapy for bladder cancer in the elderly.

Authors: D Raghavan
Journal: Drugs Aging Date: 1993 Jan-Feb Impact factor: 3.923

5. Comparison of 30 mg and 40 mg of mitomycin C intravesical instillation in Korean superficial bladder cancer patients: prospective, randomized study.

Authors: Chang Wook Jeong; Hwang Gyun Jeon; Cheol Kwak; Hyeon Jeong; Sang Eun Lee
Journal: Cancer Res Treat Date: 2005-02-28 Impact factor: 4.679

6. Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer.

Authors: T Niijima; K Koiso; H Akaza
Journal: Cancer Chemother Pharmacol Date: 1983 Impact factor: 3.333

7. Bladder cancer chemotherapy studies supported by the National Bladder Cancer Project.

Authors: G H Friedell
Journal: Cancer Chemother Pharmacol Date: 1983 Impact factor: 3.333

8. A randomized trial of early intravesical instillation of epirubicin in superficial bladder cancer. The Nagoya University Urological Oncology Group.

Authors: K Okamura; T Murase; K Obata; S Ohshima; Y Ono; T Sakata; Y Hasegawa; T Shimoji; K Miyake
Journal: Cancer Chemother Pharmacol Date: 1994 Impact factor: 3.333

9. The effects of intravesical chemoimmunotherapy with epirubicin and bacillus Calmette-Guérin for prophylaxis of recurrence of superficial bladder cancer: a preliminary report.

Authors: Y Uekado; A Hirano; T Shinka; T Ohkawa
Journal: Cancer Chemother Pharmacol Date: 1994 Impact factor: 3.333

10. Recurrence of superficial bladder tumours after transurethral resection.

Authors: H Fuse; T Sakai; H Kimura; T Katayama
Journal: Int Urol Nephrol Date: 1992 Impact factor: 2.370